Ticker Scorecard - IMVT Basics Company: Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.83B Activated in VL: True Average Daily Range Avg Daily Range: $0.54 | 2.78% Avg Daily Range (30 D): $0.52 | 2.00% Avg Daily Range (90 D): $0.57 | 2.00% Institutional Daily Volume Avg Daily Volume: .78M Avg Daily Volume (30 D): .76M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 60 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 2,448 Avg Inst. Trade: $2.19M Avg Inst. Trade (30 D): $3.15M Avg Inst. Trade (90 D): $2.5M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.42M Avg Closing Trade (30 D): $4.66M Avg Closing Trade (90 D): $3.85M Avg Closing Volume: 144.51K     News Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Sep 9, 2024 @ 7:55 AM Immunovant Provides Update on Graves’ Disea... Source: N/A Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 28, 2024 @ 3:30 PM Immunovant (IMVT) Down 1.6% Since Last Earnings Re... Source: Zacks Equity Research May 30, 2024 @ 3:29 PM Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipel... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.74 $-.6 $-.52 Diluted EPS $-.74 $-.6 $-.52 Revenue $ $ $ 8.38M Gross Profit $ $ $ Net Income / Loss $ -109.12M $ -87.15M $ -75.32M Operating Income / Loss $ $ $ -72.5M Cost of Revenue $ $ $ Net Cash Flow $ -87.06M $ -75.36M $ -55.57M PE Ratio